CRISPR/CasX-Mediated Gene Editing as a Therapeutic Approach for HSV-1 Keratitis

被引：0

作者：

Ruan, Guoxiang ^{[1
]}

Amrani, Nadia ^{[1
]}

Luk, Kevin ^{[1
]}

Isik, Meltem ^{[1
]}

Bhattacharya, Sarmistha ^{[2
]}

Donegan, Niles P. ^{[3
]}

Donadoni, Martina ^{[4
]}

Bellizzi, Anna ^{[4
]}

Sariyer, Ilker K. ^{[4
]}

Hayden, Matthew ^{[2
]}

Gordon, Jennifer ^{[1
]}

机构：

[1] Excis BioTherapeut, Watertown, MA USA

[2] Dartmouth Hlth, Lebanon, NH USA

[3] White River Junction Vet Affairs Med Ctr, White River Jct, VT USA

[4] Temple Univ, Sch Med, Philadelphia, PA USA

来源：

MOLECULAR THERAPY | 2024年 / 32卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

1188

引用

页码：565 / 566

页数：2

共 50 条

[31] Single AAV-Mediated CRISPR-SaCas9 Inhibits HSV-1 Replication by Editing ICP4 in Trigeminal Ganglion Neurons
Chen, Yuxi
Zhi, Shengyao
Liang, Puping
Zheng, Qi
Liu, Mengni
Zhao, Qi
Ren, Jian
Cui, Jun
Huang, Junjiu
Liu, Yizhi
Zhou Songyang
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 18 : 33 - 43
[32] PET imaging of HSV-1 amplicon vector-mediated gene expression
Jacobs, AH
Winkeler, A
Dittmar, C
Hartung, M
Slack, M
Kummer, C
Wienhard, K
Heiss, WD
EUROPEAN JOURNAL OF CANCER, 2002, 38 : S144 - S144
[33] Type 1 and Type 2 cytokines in murine HSV-1 keratitis.
Bauer, D
Heiligenhaus, A
Zheng, M
Steuhl, KP
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 4080 - 4080
[34] Macrophage-depletion influences the course of murine HSV-1 keratitis
Bauer, D
Mrzyk, S
van Rooijen, N
Steuhl, KP
Heiligenhaus, A
CURRENT EYE RESEARCH, 2000, 20 (01) : 45 - 53
[35] Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study
Heiligenhaus, A
Steuhl, KP
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1999, 237 (05) : 435 - 438
[36] AN ANTISENSE OLIGONUCLEOTIDE TO THE HSV-1 UL-13 GENE IS EFFECTIVE AGAINST HERPETIC-KERATITIS
BRANDT, CR
COAKLEY, LM
GRAU, DR
DRAPER, KG
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 854 - 854
[37] EXPERIMENTAL KERATITIS IN RABBITS BY HUMAN HSV-1 VARIANTS - PREVENTION AND TREATMENT
MANSERVIGI, R
INCORVAIA, C
DILUCA, D
ROTOLA, A
BALBONI, PG
SEBASTIANI, A
ROSSI, A
CASSAI, E
JOURNAL OF MEDICAL VIROLOGY, 1990, 32 (03) : 148 - 154
[38] Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study
A. Heiligenhaus
Klaus-Peter Steuhl
Graefe's Archive for Clinical and Experimental Ophthalmology, 1999, 237 : 435 - 438
[39] CRISPR/Cas9-mediated genome editing of the thymidine kinase gene in a clinical HSV-1 isolate identifies F289S as novel acyclovir-resistant mutation
Zheng, Shuxuan
Verjans, Georges M. G. M.
Evers, Anouk
van den Wittenboer, Ellen
Tjhie, Jeroen H. T.
Snoeck, Robert
Wiertz, Emmanuel J. H. J.
Andrei, Graciela
van Kampen, Jeroen J. A.
Lebbink, Robert Jan
ANTIVIRAL RESEARCH, 2024, 228
[40] HSV-1 VECTOR MEDIATED NEURONAL GENE DELIVERY - STRATEGIES FOR MOLECULAR NEUROSCIENCE AND NEUROLOGY
FREESE, A
GELLER, AI
NEVE, R
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (10) : 2189 - 2199

← 1 2 3 4 5 →